These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 2314840)

  • 1. Transcriptomic profiles of retinal ganglion cells are defined by the magnitude of intraocular pressure elevation in adult mice.
    Park YH; Snook JD; Ostrin EJ; Kim S; Chen R; Frankfort BJ
    Sci Rep; 2019 Feb; 9(1):2594. PubMed ID: 30796289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability and critical flicker fusion frequency changes during and after parachute jumping in experienced skydivers.
    Cavalade M; Papadopoulou V; Theunissen S; Balestra C
    Eur J Appl Physiol; 2015 Jul; 115(7):1533-45. PubMed ID: 25715913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity and specificity of flicker perimetry with Pulsar. Comparison with achromatic (white-on-white) perimetry in glaucoma patients].
    Göbel K; Erb C
    Ophthalmologe; 2013 Feb; 110(2):141-5. PubMed ID: 23338528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of critical flicker fusion frequency impairment after a 33 mfw SCUBA dive: evidence of prolonged nitrogen narcosis?
    Balestra C; Lafère P; Germonpré P
    Eur J Appl Physiol; 2012 Dec; 112(12):4063-8. PubMed ID: 22476770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo.
    Sehi M; Grewal DS; Feuer WJ; Greenfield DS
    Vision Res; 2011 Jan; 51(2):235-42. PubMed ID: 20813123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma.
    Sun H; Swanson WH; Arvidson B; Dul MW
    Vision Res; 2008 Nov; 48(26):2633-41. PubMed ID: 18501947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglion cell loss and age-related visual loss: a cortical pooling analysis.
    Pearson PM; Schmidt LA; Ly-Schroeder E; Swanson WH
    Optom Vis Sci; 2006 Jul; 83(7):444-54. PubMed ID: 16840870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two methods of lens opacity measurements in glaucomas.
    Horn FK; Jünemann AG; Korth M
    Doc Ophthalmol; 2001 Sep; 103(2):105-17. PubMed ID: 11720254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal contrast sensitivity with peripheral and central stimulation in glaucoma diagnosis.
    Velten IM; Korth M; Horn FK; Budde WM
    Br J Ophthalmol; 1999 Feb; 83(2):199-205. PubMed ID: 10396199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-field S-cone flicker test.
    Budde WM; Korth M; Mardin CY
    Graefes Arch Clin Exp Ophthalmol; 1997 Jul; 235(7):415-24. PubMed ID: 9248837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motion discrimination of single targets: comparison of preliminary findings in normal subjects and patients with glaucoma.
    Sahraie A; Barbur JL; Edgar DF; Weiskrantz L
    Graefes Arch Clin Exp Ophthalmol; 1996 Sep; 234(9):553-60. PubMed ID: 8880153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Vistech contrast sensitivity and visual field findings in glaucoma.
    Sponsel WE; DePaul KL; Martone JF; Shields MB; Ollie AR; Stewart WC
    Br J Ophthalmol; 1991 Sep; 75(9):558-60. PubMed ID: 1911660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the association of alpha and beta-blocking agents in glaucoma.
    Bonomi L; Marchini G; Marraffa M; De Franco I; Perfetti S; Ferri E
    J Ocul Pharmacol; 1992; 8(4):279-83. PubMed ID: 1362436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications.
    Lazreg S; Merad Z; Nouri MT; Garout R; Derdour A; Ghroud N; Kherroubi R; Meziane M; Belkacem S; Ouhadj O; Baudouin C; Tiar M
    J Fr Ophtalmol; 2018 Dec; 41(10):945-954. PubMed ID: 30477719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE; Perry CM
    Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flicker sensitivity in treated ocular hypertension.
    Tytla ME; Trope GE; Buncic JR
    Ophthalmology; 1990 Jan; 97(1):36-43. PubMed ID: 2314840
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.